What this means
This is a planned study that has not started enrolling people yet. It will compare aging markers in patients who reach diabetes remission and those who do not, but no results exist yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 35–70
- Where
- Not listed
The science
- Registered title
- The Impact of Diabetes Remission on Aging
- Trial ID
- NCT07736040 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Type 2 Diabetes
- What is tested
- Comprehensive Lifestyle Intervention
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Ages
- 35 Years to 70 Years
- Dates
- First posted Jul 30, 2026 · updated Jul 30, 2026
Registry summary
This study is a real-world, prospective clinical cohort study. It will enroll Chinese patients with type 2 diabetes. The aim is to assess the changes in aging biomarkers, primarily DunedinPACE, from baseline to post-remission, and to compare these biomarkers between patients who achieve successful remission and those who do not.